Evidence map›Paper›PMID 37038395›Full record

ArticleCrystal growth & design2023

Conglomerate Crystallization in the Cambridge Structural Database (2020-2021).

Mark P Walsh, James A Barclay, Callum S Begg, Jinyi Xuan, Matthew O Kitching

Abstract read
In one paragraph

Article in Crystal growth & design, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Dihydrobenzofuro[3,2-Chemical science · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mark P WalshProcess Research and Development, Carbogen Amcis Ltd., 303 Clayton Lane, Manchester, M11 4SX, U.K.ORCID https://orcid.org/0000-0003-3185-2460
James A BarclayDepartment of Chemistry, Durham University, Lower Mount Joy, South Rd., Durham, DH1 3LE, U.K.ORCID https://orcid.org/0000-0002-2741-7514
Callum S BeggDepartment of Chemistry, Durham University, Lower Mount Joy, South Rd., Durham, DH1 3LE, U.K.ORCID https://orcid.org/0000-0002-8727-3444
Jinyi XuanDepartment of Chemistry, Durham University, Lower Mount Joy, South Rd., Durham, DH1 3LE, U.K.ORCID https://orcid.org/0000-0002-0604-4050
Matthew O KitchingDepartment of Chemistry, Durham University, Lower Mount Joy, South Rd., Durham, DH1 3LE, U.K.ORCID https://orcid.org/0000-0001-8276-583X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conglomerate crystals are materials capable of undergoing spontaneous resolution and were responsible for the discovery of molecular chirality. Their relevance to modern chemical and crystallographic sciences has been hindered by the difficulty in identifying and searching materials with this characteristic ability to spontaneously bias their own enantioenrichment. With the release of the November 2021 distribution of the Cambridge Structural Database (CSD) (version 5.43), a fresh quantity of chiral conglomerate crystals is expected to have been published in the CSD without identification. Indeed, no crystals in the CSD have been identified as a spontaneously resolving conglomerate crystal in their crystallographic information file since the 2019 release, despite the deposition of over 108,000 new crystal structures into the database over the same time period. A manual inspection of crystals deposited between 2020 and 2021 was conducted to identify 343 new chiral materials which exhibit conglomerate crystallization behavior. It is hoped that the continued manual curation of this list will aid those in the crystallographic and synthetic communities to study and exploit this spontaneous enantioenrichment behavior.

Identifiers

PMID37038395
PMCPMC10080650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.